摘要
我院于１９９３年１２月至１９９７年１０月用１３１碘治疗甲状腺机能亢进症（简称甲亢）病人５０４０例中，应用“甲亢舒”配合１３１碘治疗（简称治疗组）４２６５例；单用１３１碘治疗（简称对照组）７７５例。在应用１３１碘治疗的“空白区”期间对病人病情进行系统观察，结果表明：１．症状加重治疗组为２．２３％，对照组为９２．３９％（Ｐ＜０．０１）；２．甲亢危象发生率治疗组为０％，对照组为２．４５％（Ｐ＜０．０１）；３．治疗４周时甲亢症状改善治疗组明显优于对照组（Ｐ＜０．０１）；４．血清ＦＴ３、ＦＴ４浓度变化：治疗组明显下降，对照组虽有下降，但下降的速度也不如治疗组（Ｐ＜０．０５）。５．甲亢舒能明显提高１３１碘疗效。表明“甲亢舒”配合１３１碘治疗甲亢，能迅速缓解临床症状，降低血清ＦＴ３、ＦＴ４浓度；减少１３１碘治疗的并发症；增加１３１碘的治疗效果。
Between December 1993 and October 1997,5040 cases with hyperthyroidism were treated with131I in our hospital,and 4265 of the above-mentioned patients were treated with combined 131I and Jia kang shu(treated group),the other 775 cases were treated only with 131I(contrast group)The clinical result showed that:(1)Symptom exacerbation in treated group was 223%,and 9239%(P<001)in contrast group;(2)Crisis incidence of hyperthyroidism was 0% in treated group,and 245%(P<001)in contrast group;(3)Symptom improvement during 4th week treatment in treated group was obviously better than that in contrast group (P<001);(4)A marked drop of the concentration of serus FT 3、FT 4 happened in treated group,and there was only a little in contrast group(P<005);(5)Jia kang shu could markedly improve the therapeutic effect of 131I Based on these findings,we concluded that the effect of treatment combined 131I and Jia kang shu in hyperthyriodism was better than that of only with 131I,it could relief the clinical symptom,lower concentration of serus FT 3、FT 4,reduce the complication and reinforce the effect of 131I \ \
出处
《广西医学》
CAS
1998年第4期534-537,共4页
Guangxi Medical Journal
